Omega-3 Fatty Acids: What They Actually Do (and Don't Do)

The Most Popular Supplement That’s Mostly Misunderstood

Fish oil capsules sit in more medicine cabinets than almost any other supplement. Roughly 10% of Americans take omega-3 supplements regularly, often because they’ve heard it’s “good for the heart” or “good for the brain.” But the reality is more nuanced than the marketing suggests. Some omega-3 benefits are rock-solid. Others have crumbled under the weight of large, well-designed trials.

EPA vs DHA: They’re Not the Same

Omega-3 fatty acids come primarily in two bioactive forms: EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid). Most fish oil capsules contain both, but they serve different biological roles.

EPA is primarily anti-inflammatory. It competes with arachidonic acid (an omega-6) for incorporation into cell membranes and produces less inflammatory signaling molecules called resolvins and protectins. EPA is the form most strongly linked to inflammation reduction and triglyceride lowering.

DHA is a structural component of brain cell membranes and retinal tissue. It’s critical during fetal development and early childhood. However, in healthy adults with adequate diets, supplementing extra DHA has shown disappointing results for cognitive enhancement.

This distinction matters because many studies — and many supplements — use a blend of both at relatively low doses, making it hard to attribute benefits to one or the other.

What Omega-3 Actually Helps: Strong Evidence

Triglyceride Reduction

This is the clearest, most replicated benefit. High-dose omega-3 (2-4g of EPA+DHA daily) reliably reduces triglycerides by 15-30%. This is strong enough that prescription omega-3 formulations (Vascepa, Lovaza) exist specifically for this purpose. The evidence for omega-3 and triglyceride reduction is robust across dozens of RCTs.

Systemic Inflammation

EPA in particular reduces inflammatory markers like CRP and IL-6, though the effect sizes are modest — typically 10-15% reductions. This is meaningful for people with elevated baseline inflammation but unlikely to be noticeable for someone with normal inflammatory markers.

Depression (Adjunct Therapy)

Meta-analyses suggest EPA-dominant formulations (at least 60% EPA) at doses above 1g may provide modest benefit for clinical depression when added to standard treatment. The effect is small but statistically significant. Check our analysis of omega-3 and depression. Importantly, this is as an adjunct — omega-3 is not a replacement for evidence-based depression treatments.

What Omega-3 Doesn’t Do: Overhyped Claims

Prevent Heart Attacks in the General Population

This is the big one. For decades, observational studies suggested fish eaters had fewer heart attacks. But when researchers ran large RCTs — ASCEND (15,000+ participants), VITAL (25,000+ participants), STRENGTH (13,000+ participants) — most found no significant reduction in major cardiovascular events from standard-dose fish oil supplementation.

The exception is REDUCE-IT, which used very high-dose pure EPA (4g/day of icosapent ethyl) in statin-treated patients with elevated triglycerides, showing a 25% reduction in cardiovascular events. But this is a pharmaceutical dose of a specific form in a specific population — not your standard fish oil capsule.

Boost Brain Function in Healthy Adults

Despite DHA being critical for brain structure, supplementing omega-3 in cognitively healthy adults has consistently failed to improve memory, processing speed, or executive function in RCTs. The brain appears to maintain adequate DHA levels from normal dietary intake in most people.

Cure Arthritis

While omega-3 may modestly reduce joint stiffness and pain in rheumatoid arthritis, the effects are small and don’t approach the efficacy of standard treatments. It won’t reverse structural joint damage.

Dosing: Why Most Studies Are Underdosed

A standard fish oil capsule contains about 300mg of combined EPA+DHA (in a 1000mg capsule — the rest is other fats). To reach the 2-4g daily dose where most benefits are demonstrated, you’d need 7-13 standard capsules. Most people take 1-2.

This is a major reason why some RCTs fail to find effects — they use doses that are pharmacologically insufficient. When evaluating omega-3 research, always check the actual EPA+DHA dose, not just “fish oil.”

Fish Oil vs Algae Oil

Traditional fish oil comes with sustainability concerns, potential heavy metal contamination, and an unpleasant aftertaste. Algae-derived omega-3 provides DHA (and increasingly EPA) without these issues. It’s also the only option for vegans.

Bioavailability studies show algal DHA absorbs comparably to fish-derived DHA. For EPA specifically, algal sources are newer and less extensively studied, but early data looks equivalent.

Who Actually Needs Omega-3 Supplementation

Strong case for supplementation:

• People with elevated triglycerides (at therapeutic doses)
• Those eating very little fatty fish (less than one serving per week)
• Pregnant and breastfeeding women (DHA for fetal brain development)
• People with clinical depression (EPA-dominant, as adjunct therapy)

Weak case for supplementation:

• People eating fatty fish 2-3 times per week (already meeting needs)
• Healthy adults hoping for cognitive enhancement
• General population for “heart health” at standard supplement doses

Key Takeaway

Omega-3 is not a miracle supplement, but it’s not useless either. It genuinely reduces triglycerides at adequate doses and modestly helps inflammation and depression. But the vague “good for your heart and brain” marketing vastly oversells what standard-dose fish oil can do for healthy people. If you supplement, choose a concentrated formula with at least 1g combined EPA+DHA, know what specific outcome you’re targeting, and set realistic expectations.